新冠疫苗传来大利好！Moderna疫苗对“德尔塔”毒株产生抗体，股价大涨创新高
The arrival of the COVID-19 vaccine is a big plus! The Moderna vaccine produced antibodies to the “Delta” strain, and the stock price soared to a record high
The US company Moderna, one of the manufacturers of the COVID-19 vaccine, recently stated that the company's vaccine produced sufficient levels of antibodies against the “Delta” strain of the coronavirus currently spreading. This news prompted Moderna's stock price to reach a record high in the intraday period.
According to research published earlier by Moderna, the company's vaccine also produced neutralizing antibodies against the previous three COVID-19 strains (alpha, beta, and gamma).
Driven by Moderna, many vaccine stocks followed suit, and the vaccine sector outperformed the market.
According to research published earlier by Moderna, the company's vaccine also produced neutralizing antibodies against the previous three COVID-19 strains (alpha, beta, and gamma).
Driven by Moderna, many vaccine stocks followed suit, and the vaccine sector outperformed the market.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.